News

2016 Québec Science Discovery of the Year People’s Choice award for a major breakthrough in Cancer Research, for which IRIC collaborated

Professor Sylvain Martel, Director of the Polytechnique Montréal Nanorobotics Laboratory, and a team of researchers from Polytechnique Montréal, Université de Montréal and McGill University have achieved a major leap forward in cancer research by developing new nanorobotic agents able to navigate through the bloodstream to administer a drug with precision by specifically targeting the active […]

New antithrombotic drug developed through a research partnership between IRIC and Bristol-Myers Squibb

An article describing the identification and development of a new molecule to treat thrombotic diseases via a partnership with Bristol-Myers Squibb (BMS) was published in the January 4 edition of the prestigious scientific journal Science Translational Medicine. This molecule, BMS-986120, acts on cellular receptor PAR4 involved in the activation of blood platelets in clot formation. […]

A new proteomics approach reveals the importance of SUMOylation and its role in protein degradation in PML nuclear bodies

The team of Pierre Thibault, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) and professor in the Department of Chemistry of the Université of Montréal, in collaboration with colleagues from the University Paris-Descartes recently published in the journal Nature Communications a new proteomics approach for the global-scale analysis of protein SUMOylation with unprecedented […]

ONCOPOLE: A research, development, and investment hub to accelerate the fight against cancer

A $15 million investment from Merck Merck & Co., Inc., and the Fonds de recherche du Québec – Santé (FRQS) are proud to announce the creation of Oncopole: a research, development, and investment hub to accelerate the fight against cancer. The Oncopole is starting with a solid foundation with a $15-million financial commitment over three […]

Delphine Bouilly Joins IRIC as a Principal Investigator

The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM) is happy to announce that Delphine Bouilly is joining its team as Principal Investigator, Design and Application of Electronic Nanobiosensors research unit. She will also serve as assistant professor in the Physics Department of the Faculty of Arts and Science […]

Michel Bouvier receives the Julius Axelrod Award for his contributions as a scientist and mentor

Professor Michel Bouvier, Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM) and professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine, was named recipient of the Julius Axelrod Award in Pharmacology-2017 given by the American Society for Pharmacology and Experimental […]

IRIC expands its medicinal chemistry core facility and announces the launch of phase II clinical trials for a molecule jointly identified by IRIC and Bristol-Myers Squibb

On Wednesday, December 14, new laboratories for the medicinal core facility at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM) were inaugurated. This core facility, primarily located at the Marcelle Coutu Pavilion at IRIC, will increase drug discovery capacity and speed up the expansion of its chemical compounds […]

IRIC presents 18 doctoral scholarships and conference awards to students of the Institute

The Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal is proud to present a new series of doctoral scholarships and conference awards to several students of the Institute. The doctoral scholarship competition aims to support Ph.D. students at IRIC with an excellent academic standing and who do not benefit from any […]

Chemical compounds identified to target preleukemic stem cells

A study published in The Journal of Clinical Investigation brings to light the recent advances made in the laboratory of Dr. Trang Hoang, Principal Investigator and Head of the Hematopoiesis and Leukemia research unit of the Institute for Research in Immunology and Cancer at the Université de Montréal. This study examines T cell acute lymphoblastic leukemia (T-ALL), […]

Bianca Plouffe Stands out at Concours Étudiants-Chercheurs Étoiles

This October, a new student ranked in the List of Étudiants-Chercheurs Étoiles: Bianca Plouffe, a postdoctoral researcher in biochemistry in the laboratory of Michel Bouvier from the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM), is a prize winner in the “Health” section of Fonds de Recherche du Québec. Bianca […]

Next Page »

Follow IRIC

Logo UdeM